Our work expands upon this body of literature, showing that GSK3β inhibition may attenuate diabetes-induced autophagy impairment in HAECs by increasing autophagosome formation, potentially by Akt/AMPK-FOXO1 signalling. Here, GSK3B is linked to diabetes mellitus.